Social and Administrative Aspects of Pharmacy in Low- And Middle-Income Countries
Present Challenges and Future Solutions
Herausgeber: Ibrahim, Mohamed Izham Mohamed; Babar, Zaheer-Ud-Din; Wertheimer, Albert
Social and Administrative Aspects of Pharmacy in Low- And Middle-Income Countries
Present Challenges and Future Solutions
Herausgeber: Ibrahim, Mohamed Izham Mohamed; Babar, Zaheer-Ud-Din; Wertheimer, Albert
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
'Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries' examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the first-hand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy provisions.--
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Produktdetails
- Verlag: Elsevier Science Publishing Co Inc
- Seitenzahl: 484
- Erscheinungstermin: 24. Oktober 2017
- Englisch
- Abmessung: 194mm x 237mm x 27mm
- Gewicht: 984g
- ISBN-13: 9780128112281
- ISBN-10: 012811228X
- Artikelnr.: 48138327
- Verlag: Elsevier Science Publishing Co Inc
- Seitenzahl: 484
- Erscheinungstermin: 24. Oktober 2017
- Englisch
- Abmessung: 194mm x 237mm x 27mm
- Gewicht: 984g
- ISBN-13: 9780128112281
- ISBN-10: 012811228X
- Artikelnr.: 48138327
Middle-Income Countries Section I: Socio-behavioral Aspects of Medicines
Used in Low- and Middle-Income Countries 2. Socio-Behavioral Aspects of
Medicine Used in Low- and Middle-Income Countries 3. Patients', Consumers'
and Healthcare Professionals' Perceptions, Beliefs, Knowledge, Attitudes
and Practices Towards the Use of Medicines 4. The Use of Measurements and
Health Behavioral Models to Improve Medication Adherence
Section II: Pharmaceutical Promotion in Low- and Middle-Income Countries
5. Academic Detailing in Low- and Middle-Income Countries: Principles, Use,
Impact and Lessons Learned Section III: Economic Evaluation and Medicine
Expenditure in Low- and Middle-Income Countries 6. Economic Evaluation and
Medicine Expenditure in Low- and Middle-Income Countries 7. Medicine
Pricing Policy and Strategies in Low- and Middle-Income Countries: A Review
8. Economic Evaluation of Predominant Disease in Low- and Middle-Income
Countries: Diabetes Mellitus Section IV: Pharmacovigilance and Patient
Safety in Low- and Middle-Income Countries 9. Pharmacovigilance Practices
and Activities: Issues, Challenges, and Future Direction 10. Behavioral
Aspects of Pharmacovigilance: Research Methods Considerations 11.
Knowledge, Attitude, and Practice of Pharmacovigilance in Low- and
Middle-Income Countries Section V: Generic Medicines Used in Low- and
Middle-Income Countries 12. Overcoming Challenges of Generic Medicine
Utilization in Low- and Middle-Income Countries: Lessons Learned from
International Experiences 13. Assessment of Policies, Determinants and
Characteristics of Generic Medicine Entry into the Pharmaceutical Markets
Section VI: Rational and Responsible Medicine Use in Low- and Middle-Income
Countries 14. Misconceptions and Misues of Drugs by Prescribers, Dispensers
and Consumers 15. Strengths and Weaknesses of Pharmaceutical Policy in
Relation to Rational and Responsible Medicines Use 16. Rational and
Responsible Medicines Use Section VII: Quality of Public Health Pharmacy
Services in Low- and Middle-Income Countries 17. Quality of Pharmacy Health
Services 18. Assessment of Medicine Dispensing and Extended Community
Pharmacy Services 19. Enhancing Quality of Patient-Centered Care Services
in Low- and Middle-Income Countries: Pharmaceutical Care Approach 20.
Politics and Competition between Professions: Future Scope of Pharmacy
Practice Section VIII: Medicine Quality: Substandard and Counterfeit
Medicine in Low- and Middle-Income Countries 21. Perspective, Knowledge,
Attitude, and Belief of Various Stakeholders on Medicines Quality:
Counterfeit and Substandard Medicines Section IX: Medicine Information and
Health Literacy in Low- and Middle-Income Countries 22. Issues on Source,
Access, Extent and Quality of Information Available Among Pharmacists and
Pharmacy Personnel to Practice Effectively Section X: Good Governance and
Pharmaceutical Policy in Low- and Middle-Income Countries 23. Problems and
Obstacles of Low- and Middle-Income Countries in Having Good Governance and
Quality and Effective Pharmaceutical Policy 24. Pharmacogovernance:
Advancing Pharmacovigilance and Patient Safety 25. Pharmaceutical Policy:
Synthesis, Themes and Future Directions
Middle-Income Countries Section I: Socio-behavioral Aspects of Medicines
Used in Low- and Middle-Income Countries 2. Socio-Behavioral Aspects of
Medicine Used in Low- and Middle-Income Countries 3. Patients', Consumers'
and Healthcare Professionals' Perceptions, Beliefs, Knowledge, Attitudes
and Practices Towards the Use of Medicines 4. The Use of Measurements and
Health Behavioral Models to Improve Medication Adherence
Section II: Pharmaceutical Promotion in Low- and Middle-Income Countries
5. Academic Detailing in Low- and Middle-Income Countries: Principles, Use,
Impact and Lessons Learned Section III: Economic Evaluation and Medicine
Expenditure in Low- and Middle-Income Countries 6. Economic Evaluation and
Medicine Expenditure in Low- and Middle-Income Countries 7. Medicine
Pricing Policy and Strategies in Low- and Middle-Income Countries: A Review
8. Economic Evaluation of Predominant Disease in Low- and Middle-Income
Countries: Diabetes Mellitus Section IV: Pharmacovigilance and Patient
Safety in Low- and Middle-Income Countries 9. Pharmacovigilance Practices
and Activities: Issues, Challenges, and Future Direction 10. Behavioral
Aspects of Pharmacovigilance: Research Methods Considerations 11.
Knowledge, Attitude, and Practice of Pharmacovigilance in Low- and
Middle-Income Countries Section V: Generic Medicines Used in Low- and
Middle-Income Countries 12. Overcoming Challenges of Generic Medicine
Utilization in Low- and Middle-Income Countries: Lessons Learned from
International Experiences 13. Assessment of Policies, Determinants and
Characteristics of Generic Medicine Entry into the Pharmaceutical Markets
Section VI: Rational and Responsible Medicine Use in Low- and Middle-Income
Countries 14. Misconceptions and Misues of Drugs by Prescribers, Dispensers
and Consumers 15. Strengths and Weaknesses of Pharmaceutical Policy in
Relation to Rational and Responsible Medicines Use 16. Rational and
Responsible Medicines Use Section VII: Quality of Public Health Pharmacy
Services in Low- and Middle-Income Countries 17. Quality of Pharmacy Health
Services 18. Assessment of Medicine Dispensing and Extended Community
Pharmacy Services 19. Enhancing Quality of Patient-Centered Care Services
in Low- and Middle-Income Countries: Pharmaceutical Care Approach 20.
Politics and Competition between Professions: Future Scope of Pharmacy
Practice Section VIII: Medicine Quality: Substandard and Counterfeit
Medicine in Low- and Middle-Income Countries 21. Perspective, Knowledge,
Attitude, and Belief of Various Stakeholders on Medicines Quality:
Counterfeit and Substandard Medicines Section IX: Medicine Information and
Health Literacy in Low- and Middle-Income Countries 22. Issues on Source,
Access, Extent and Quality of Information Available Among Pharmacists and
Pharmacy Personnel to Practice Effectively Section X: Good Governance and
Pharmaceutical Policy in Low- and Middle-Income Countries 23. Problems and
Obstacles of Low- and Middle-Income Countries in Having Good Governance and
Quality and Effective Pharmaceutical Policy 24. Pharmacogovernance:
Advancing Pharmacovigilance and Patient Safety 25. Pharmaceutical Policy:
Synthesis, Themes and Future Directions